<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01452490</url>
  </required_header>
  <id_info>
    <org_study_id>D4-11-F</org_study_id>
    <nct_id>NCT01452490</nct_id>
  </id_info>
  <brief_title>Diode Laser Treatment of Onychomycosis</brief_title>
  <official_title>Study of the V-Raser Diode Laser System in the Treatment of Onychomycosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ConBio, a Cynosure Company</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cynosure, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the V-Raser diode laser system with investigational
      Nail Fungus Handpiece in the treatment of onychomycosis.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2011</start_date>
  <completion_date type="Actual">August 2013</completion_date>
  <primary_completion_date type="Actual">August 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Amount of Clear Nail Growth from Baseline in mm or as measurement of total area of involvement</measure>
    <time_frame>12 months</time_frame>
    <description>Amount of lesion-free toenail growth (mm or total area of involvement) from Baseline, as judged by computer software analysis of photos.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Onychomycosis</condition>
  <arm_group>
    <arm_group_label>Diode Laser Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Diode Laser Treatment</intervention_name>
    <description>Laser treatment once every 6 weeks, for a total of 4 treatment sessions</description>
    <arm_group_label>Diode Laser Treatment</arm_group_label>
    <other_name>V-Raser</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Confirmed subungual onychomycosis in a great toe that does not extend to the
             eponychium

          -  Fitzpatrick Skin Type I-IV

          -  Written and verbal informed consent

          -  Able to comply with study instructions and to return to the clinic for required visits

          -  Agrees to refrain from other active topical, laser or light-based treatment to the
             great toes

          -  Agrees to the use of Naftin Gel between the toes to prevent/control tinea pedis

        Exclusion Criteria:

          -  Pregnancy, breastfeeding or planning to become pregnant

          -  History of cutaneous photosensitivity, porphyria and hypersensitivity to porphyrins or
             photodermatoses

          -  Any skin pathology or condition that could interfere with the evaluation or that
             requires the use of interfering topical or systemic therapy

          -  Coagulation disorder or current use of anti-coagulation medication (including aspirin
             use of greater than 81 mg per day)

          -  Any condition which, in the investigator's opinion, would make it unsafe for the
             subject to participate

          -  Enrolled in an investigational drug or device trial, or has been treated with an
             investigational device or received an investigational drug within 30 days

          -  Oral Lamisil within 1 year, Sporanox or over-the-counter topicals within 1 month, or
             other prescription anti-fungal medications or topicals within 6 months

          -  Evidence of diabetic neuropathy or peripheral vascular disease related to diabetes, or
             a loss of protective sensation in the affected foot

          -  Psoriasis, lichen planus, infection involving the lunula, prior surgical treatment of
             the affected great toe within 1 year, or a history of trauma to the affected great toe

          -  Immunocompromised status, or with existing (or history of) cancer/skin malignancy

          -  Distal nail thickness of greater than 2mm in the affected great toenail
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Darren Courtright, DPM</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shoreline Foot and Ankle Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Shoreline Foot and Ankle Center</name>
      <address>
        <city>New London</city>
        <state>Connecticut</state>
        <zip>06320</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shoreline Foot and Ankle Center</name>
      <address>
        <city>Westbrook</city>
        <state>Connecticut</state>
        <zip>06498</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 11, 2011</study_first_submitted>
  <study_first_submitted_qc>October 12, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 14, 2011</study_first_posted>
  <last_update_submitted>March 25, 2014</last_update_submitted>
  <last_update_submitted_qc>March 25, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 26, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Onychomycosis</keyword>
  <keyword>Toenail Fungus</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Onychomycosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

